These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17123290)

  • 21. The model for end-stage liver disease comes of age.
    Freeman RB
    Clin Liver Dis; 2007 May; 11(2):249-63. PubMed ID: 17606205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What's left for surgical treatment of portal hypertension in cirrhosis patients?].
    Pruvot FR; Quandalle P; Paris JC
    Gastroenterol Clin Biol; 2003 Nov; 27(11):1013-20. PubMed ID: 14732847
    [No Abstract]   [Full Text] [Related]  

  • 23. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
    Freeman RB; Gish RG; Harper A; Davis GL; Vierling J; Lieblein L; Klintmalm G; Blazek J; Hunter R; Punch J
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S128-36. PubMed ID: 17123284
    [No Abstract]   [Full Text] [Related]  

  • 24. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
    Choi DX; Jain AB; Orloff MS
    J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of transjugular intrahepatic portosystemic shunt and surgical portocaval H-shunt for the treatment of colorectal variceal bleeding.
    Uemoto S; Martin AJ; Fleming W; Habib NA
    Hepatogastroenterology; 1995; 42(5):557-60. PubMed ID: 8751215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular intrahepatic portosystemic shunts for portal hypertension.
    Crecelius SA; Soulen MC
    Gastroenterol Clin North Am; 1995 Jun; 24(2):201-19. PubMed ID: 7642241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Massive lower gastrointestinal hemorrhage in patients with portal hypertensive enteropathy: a report of two cases.
    Santoro GA; Aiello C; Galloro G; Savino N; Bucci L
    Hepatogastroenterology; 1997; 44(16):1029-32. PubMed ID: 9261594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage.
    McAvoy NC; Hayes PC
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1135-41. PubMed ID: 17033431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular intrahepatic portosystemic shunt for liver transplantation.
    Zhou GW; Cai WY; Li HW; Zhu Y; Dodson F; Fung JJ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):179-82. PubMed ID: 14607734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Portal hypertension].
    Rev Gastroenterol Mex; 2002 Nov; 67 Suppl 3():40-52. PubMed ID: 12696513
    [No Abstract]   [Full Text] [Related]  

  • 33. Transjugular intrahepatic portosystemic stent shunt placement in a patient with cystic fibrosis complicated by portal hypertension.
    Fleet M; Stanley AJ; Forrest EH; Hayes PC; Redhead DN
    Clin Radiol; 2000 Mar; 55(3):236-7. PubMed ID: 10708619
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful therapy of bleeding duodenal varices by TIPS after failure of sclerotherapy.
    Jonnalagadda SS; Quiason S; Smith OJ
    Am J Gastroenterol; 1998 Feb; 93(2):272-4. PubMed ID: 9468260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
    Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic treatment of patients with portal hypertension.
    Russo MW; Brown RS
    Gastrointest Endosc Clin N Am; 2001 Jan; 11(1):1-14. PubMed ID: 11175972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIPS: safe, effective, better?
    Somberg KA
    Am J Gastroenterol; 1997 Sep; 92(9):1412-6. PubMed ID: 9317054
    [No Abstract]   [Full Text] [Related]  

  • 39. [Portal hypertension and variceal bleeding: shunt in concomitant or general prehepatic block].
    Hirner A; Ulrich A; Wolff M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():443-50. PubMed ID: 9931656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.